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1ABSTRACT
Increased airway surface liquid and decreased mucin expression 
in pendrin-deficient human airway epithelia
Hyun Jae Lee
Department of Medical Science
The Graduate School, Yonsei University
(Directed by Professor Jae Young Choi)
Pendrin is an anion exchanger whose mutations are known to cause hearing 
loss. However, recent data support the linkage between pendrin expression 
and airway diseases, such as asthma. To evaluate the role of pendrin in the 
regulation of the airway surface liquid (ASL) volume and mucin expression, 
we investigated the function and expression of pendrin and ion channels and 
anion exchangers.
Human nasal epithelial cells were cultured from 16 deaf patients carrying 
pendrin mutations (DFNB4) and 17 controls. The cells were treated with IL-
13 to induce mucus hypersecretion. ASL thickness was measured and real-
time polymerase chain reaction was performed targeting various transporters 
2and MUC5AC. Anion exchanger activity was measured using a pH-sensitive 
fluorescent probe. Periodic acid-Schiff staining was performed on the cultured 
cells and inferior turbinate tissues.
The ASL layer of the nasal epithelia from DFNB4 subjects was thicker than 
the controls, and the difference became more prominent following IL-13 
stimulation. There was no difference in anion exchange activity after IL-13 
treatment in the cells from DFNB4 patients, while it increased in the controls. 
Goblet cell metaplasia induced by IL-13 treatment seen in the controls was 
not observed in the DFNB4 cells. Furthermore, the periodic acid-Schiff 
staining-positive area was lesser in the inferior turbinate tissues from DFNB4 
patients that those from controls.
Pendrin plays a critical role in ASL volume regulation and mucin 
expression as pendrin-deficient airway epithelial cells are refractory to 
stimulation with IL-13. Specific blockers targeting pendrin in the airways may 
therefore have therapeutic potential in the treatment of allergic airway 
diseases.
-------------------------------------------------------------------------------------------------------
Key words: SLC26A4, asthma, anion channel
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I. INTRODUCTION
Pendrin, encoded by SLC26A4, is a membrane protein that exchanges 
anions such as HCO3- and I- for Cl-.1 The protein is predominantly expressed 
in the inner ear, thyroid and kidney.2-5 Pendrin presumably acts as an HCO3-
/Cl- exchanger in the inner ear, and mutations cause prelingual hearing loss 
with enlarged vestibular aqueducts (DFNB4).6-8 In the thyroid, pendrin is 
essential for I- uptake, and defects in this protein may cause goiter and 
possibly hypothyroidism. Goiter combined with hearing loss is known as 
Pendred syndrome.9,10
Pendrin is also expressed in the airway epithelia11-16 and recent data suggest 
that pendrin expression is associated with airway diseases. Pendrin expression 
4is up-regulated in airway tissues of patients with asthma and allergic 
rhinitis.11-14,17,18 Moreover, recent study showed that patients harboring bi-
allelic SLC26A4 mutations do not experience asthma,14 although the 
prevalence of asthma among these patients is not significantly lower
compared to controls due to the low numbers of subjects. Animal studies also 
showed the role of pendrin in the pathogenesis of asthma. Ovalbumin-induced 
airway hyperresponsiveness and inflammation are attenuated in pendrin-
knockout mice13,19 and the overexpression of pendrin in airway epithelia of 
mice resulted in increased airway hyperresponsiveness.13 These findings 
suggest that pendrin may play an important role in the development of asthma.
Homeostasis of the volume and composition of the airway surface liquid
(ASL) is essential for maintaining the mucociliary clearance system.20,21 ASL 
volume is regulated by the coordinated interactions of various ion transporters,
such as epithelial sodium channels (ENaC) and cystic fibrosis transmembrane 
conductance regulators (CFTR). A recent report13 indicates that pendrin is 
involved in ASL volume regulation. ASL thickness was shown to increase
following allergic cytokine, interleukin (IL)-13, stimulation in the airway 
epithelia of pendrin-knockout mice. Another interesting discovery is that
pendrin may strongly participate in the secretion of airway mucus. 
Overexpression of pendrin induces mucus hypersecretion in mice, and pendrin 
has been shown to be a key modulator of IL-13-induced mucus secretion.14
5Based on these recent findings, pendrin may be a potential new drug target 
for asthma and other inflammatory airway diseases. However, before deciding 
on the value of pendrin as a new drug target, further elucidation of the 
physiological role of pendrin in human airways is necessary because the inner 
ear and the thyroid phenotypes of pendrin knockout mice have shown to be
different from those of patients harboring SLC26A4 mutations and the 
physiology underlying ASL homeostasis and mucus secretion in human 
airways is quite different from that in animal models.
In this study, we compare the ASL thickness, mucin expression and the 
response to stimulation with IL-13 in nasal epithelial cells cultured from 
patients with SLC26A4 mutations (DFNB4) to those in controls.
6II. MATERIALS AND METHODS
1. Subjects and tissue harvesting
This study was approved by the Institutional Review Board of the Yonsei 
University Health System. Human nasal mucosa was obtained from the 
inferior turbinates of 16 deaf patients harboring bi-allelic SLC26A4 mutations
(DFNB4) during cochlear implantation. Nasal mucosa was also harvested in 
17 controls whom underwent septoplasty for correction of deviated nasal 
septum. These controls had no history of allergic rhinitis or chronic sinusitis,
and a genetic study confirmed they did not carry any SLC26A4 mutations. A 
genetic analysis confirmed the presence of the bi-allelic SLC26A4 mutation in 
all 16 deaf patients. The genotypes of the DFNB4 patients were as follows: 
H723R homozygote (n=6), H723R/IVS7-2A>G (n=6), IVS7-2A>G 
homozygote (n=2), IVS7-2A>G/M147V (n=1) and IVS7-2A>G/I302K (n=1).
(Table 1) shows the characteristics of the subjects.
Table 1. Subject Characteristics
N Age Male (no. [%]
DFNB4* 16 18 ± 12 8 (50)
Control 17 25 ± 7 10 (59)
* patients with bi-allelic mutation in SLC26A4.
72. Cell culture and IL-13 treatment
Primary cultures of human nasal epithelial (HNE) cells were obtained as 
previously described.22 Passage-2 cells were seeded into a Transwell-Clear 
culture insert with a 0.45-μm pore size (Costar Co., Cambridge, MA, USA) at 
a density of 2 x 105 cells/cm2. The cells were maintained in a 1:1 mixture of 
Dulbecco’s modified Eagle’s medium (Lonza, Walkersville, MD, USA) and 
bronchial epithelial growth medium (Lonza), supplemented with the 
following growth factors according to the manufacturer’s instructions: 
hydrocortisone (0.5 μg/ml), insulin (5 μg/ml), transferrin (10 μg/ml), 
epinephrine (0.5 μg/ml), triiodothyronine (6.5 μg/ml), gentamicin (50 μg/ml),
amphotericin B (50 μg/ml), retinoic acid (15 ng/ml), bovine pituitary extract 
(50 μg/ml), bovine serum albumin (1.5 μg/ml) and epidermal growth factor 
(0.5 ng/ml). The cells were maintained submerged for the first 7 days, after 
which they were exposed to the apical air interface for the remainder of the 
culture period. The cells were used between 14 and 21 days after the
establishment of the air-liquid interface. At all stages of culture, the cells were 
maintained at 37°C under 5% CO2 in an air incubator. To stimulate the cells, 
they were treated basolaterally with 10 ng/ml of recombinant human IL-13 
(R&D Systems, Minneapolis, MN, USA) for 7 days.
3. Quantitative Real-time PCR
8Total RNA was isolated from primary cultures of HNE cells from five
patients harboring bi-allelic SCL26A4 mutations and four controls. RNA was 
isolated using the TRIzol reagent (Invitrogen, San Diego, CA, USA) 
according to the manufacturer's protocol. Purified RNA samples were reverse
transcribed with a cDNA Synthesis Kit (Applied Biosystems, Foster City, CA) 
according to the manufacturer’s instructions. Quantitative Real-time PCR for 
pendrin, epithelial sodium channel (ENaC) α, β, γ, CFTR, ANO-1, Anion 
exchanger (AE) 2, AE3, AE4 and SLC26A3, SLC26A6, SLC26A7, SLC26A8,
SLC26A9, SLC26A11, MUC5AC was performed using the 7300 Real-Time 
PCR System (Applied Biosystems) and the DyNAmoHSSYBR Green qPCR 
Kit (Finnzymes, Espoo, Finland). The primers employed for real time PCR 
are listed in Table S1.
4. Measurement of ASL thickness
The thickness of the ASL was measured in HNE cells using a modified
version of the method described by Terran et al.21 Briefly, the cells were 
washed, and 20 μl of PBS containing 0.2% (v/v) Texas Red-dextran 
(Invitrogen) was added onto the apical cell surface to label the ASL layer. A 
100-μl aliquot of perfluorocarbon (Fluorinert FC-770; 3M, St. Paul, MN, 
USA) was then added to the apical surface to prevent evaporation of the ASL. 
After 12 hr, the cultures were transferred to the stage of an inverted confocal
9microscope (LSM 700; Carl Zeiss MicroImaging Inc.), and the height of the 
ASL was measured at five predetermined points in the cultures (one central, 
four circumferential) via XZ scans. Images were reconstructed 3-
dimensionally and analyzed using Imaris 7.1 software (Bitplane Co, Zurich, 
Switzerland).
5. Short circuit current 
Human nasal epithelial cells were mounted in Ussing chambers 
(Physiologic Instruments, San Diego, CA). Amiloride, CFTRinh-172, ATP 
were added to the apical solution, and an equal volume of vehicle was added 
at the same time to the basolateral solution. Symmetrical HCO3--buffered 
solutions (120 mM NaCl, 5 mM KCl, 1 mM MgCl2,1mM CaCl2, 10 mM D-
glucose, 5 mM HEPES, and 25 mM NaHCO3, pH 7.4)were used for human 
nasal epithelial cells. Cells were bathed for a 10 min stabilization period and 
aerated with 95% O2/5% CO2 at 37 °C or room temperature. Short circuit 
current was measured using an EVC4000 MultiChannel V/I Clamp (World 
Precision Instruments, Sarasota, FL) and recorded using PowerLab/8sp (AD 
Instruments, Castle Hill, Australia).
6. Measurement of anion exchange activity
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Measurements of the pHi in the HNE cells were performed with a pH-
sensitive fluorescent probe, bis-carboxyethyl-carboxyfluorescein (BCECF)
(Invitrogen, San Diego, CA, USA), as described previously.23 Briefly, the 
measurements were performed in PBS- or IL-13-treated cells, in which a
cluster of cells showing green fluorescent protein (GFP) fluorescence was 
exposed to BCECF, and the pHi was monitored. After adding BCECF, the 
cells were perfused with HCO3-buffered solution (120 NaCl, 5 KCl, 1 MgCl2, 
1 CaCl2, 10 D-glucose, 5 HEPES and 25 NaHCO3 in mmol/l, pH 7.4), and
BCECF fluorescence was recorded at excitation wavelengths of 490 nm and 
440 nm at a resolution of 2 sec on a recording setup (Delta Ram; PTI Inc., 
Birmingham, NJ, USA). The Cl-/HCO3- exchange activities were estimated 
from the initial rate of the pHi increase as a result of Cl- removal in the HCO3--
containing buffer (25 mM HCO3- with 5% CO2). The intrinsic buffer capacity 
(βi) was measured as described previously.23
7. Histology and periodic acid-Schiff (PAS) staining
Periodic acid-Schiff (PAS) staining was performed with a PAS staining kit 
(Sigma, St. Louis, MO, USA) according to the manufacturer's protocol. The 
harvested nasal mucosa and HNE cells on the transwell inserts were gently 
washed with PBS and fixed with 4% paraformaldehyde. After 
deparaffinization and hydration, the slides were immersed in periodic acid 
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solution for 5 min at room temperature. After being rinsed in distilled water, 
the slides were immersed in Schiff’s reagent for 15 min at room temperature, 
and then washed in running tap water for 5 min. Slides were counterstained in 
Hematoxylin Solution for 90 sec and then rinsed in running tap water, 
dehydrated, cleared and permanently mounted. For morphometric analysis, 
images of the PAS-stained slides (five different slides of tissue from each 
patient) were acquired with a Leica DM750 LED microscope and PAS-
positive cells were counted. 
8. Statistics
Statistical analysis was performed with SPSS software for PC, version 19
(SPSS Inc., Chicago, IL). Differences between groups regarding anion 
exchange activities and the rates of pendrin positivity were evaluated via one-
way analysis of variance. A p-value of less than 0.05 was considered 
statistically significant.
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III. RESULTS
1. ASL thickness; DFNB4 patients vs. controls
First, we measured the ASL thickness in HNE cells from patients harboring 
SLC26A4 mutations (DFNB4) and controls. Twelve hours after PBS/Texas 
Red-dextran loading, the ASL thickness in the DFNB4 patients (14.1 ± 2.9 μm) 
was thicker than that in the controls (8.0 ± 2.1 μm, p<0.05). The increase in 
ASL thickness following IL-13 stimulation was more prominent in DFNB4 
cells (31.3 ± 7.6 μm) than in controls (13.5 ± 2.8 μm) (Figure 1).
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Figure 1. ASL thickness in human nasal epithelia from patients harboring 
SLC26A4 mutations (DFNB4) and controls. Confocal images (A) and 
summary of ASL thickness measurements (B) at 12 hr after the apical addition 
of 20 μl of PBS containing Texas Red-dextran to primary nasal epithelial 
cultures from DFNB4 patients (n=5) and controls (n=4) in the absence or 
presence of IL-13 (10 ng/ml). Scale bars, 10 μm. * p<0.05, ** 
p<0.01,compared with the controls. Error bars, S.E.
2. Expression pattern of mRNAs encoding Na+ and Cl- channels
We compared the mRNA expression patterns of ion transporters involved in 
ASL volume regulation to rule out the possibility that the difference in ASL 
thickness between the pendrin mutants and controls stemmed from the 
differential expression of these transporters. The expression patterns of ENaC 
subtypes α, β, and γ and ANO-1 were similar between DFNB4 patients and 
controls. However, CFTR showed lower expression in the DFNB4 patients 
(0.36 ± 0.25 fold of that in the controls) (Figure 2).
When the HNE cells from controls were treated with IL-13, ENaC subtypes 
β and γ were down-regulated, whereas ANO-1 (49 ± 18 fold of PBS) was up-
regulated. As previously reported, pendrin expression was also greatly
increased by 104 ± 27 fold following treatment with IL-13. The response of 
the pendrin-deficient epithelial cells to IL-13 treatment was similar to the 
14
response in the controls: ENaC subtypes β and γ were down-regulated, and
ANO-1 was up-regulated (61 ± 26 fold) (Figure 3).
Short circuit current measurements in HNE cells showed these expression 
patterns. IL-13-treated HNE cells from control showed decreased amiloride 
sensitive ENaC current and increased CaCC current. In DFNB4 cells, IL-13 
treatment had no effect on ENaC and CFTR current, but had increased CaCC 
current following ATP stimulation (Figure 4). 
Figure 2. Expression of epithelial sodium channels (ENaC) and Cl-
channels (CFTR and ANO-1) in human nasal epithelial cells from 
patients harboring SLC26A4 mutations (DFNB4) and controls. The 
expression patterns in the cells from patients with DFNB4 (n=3) are similar to 
those in controls (n=3), except for CFTR, which shows low levels of 
15
expression in the epithelia from DFNB4 patients. * indicates p<0.05, 
compared to controls.
Figure 3. Changes in ion channel expression in response to IL-13 
treatment (10 ng/ml). In both the control (n=3) and SLC26A4 mutant 
(DFNB4) (n=3) nasal epithelia, ENaC β and γ expression are suppressed, and 
ANO-1 expression is greatly increased (by more than 50 fold) following IL-
13 treatment. In the control epithelia, pendrin is also upregulated 
(approximately 100 fold) following IL-13 treatment. * indicates p<0.05.
16
Figure 4. Changes in ion channel activity in response to IL-13 treatment 
(10 ng/ml). (A) Short circuit current measured in HNE cells from control.
Amiloride (10 µM)-sensitive Na+ current was decreased by IL-13 treatment. 
CFTR was activated by 10 µM forskolin and inhibited by CFTRinh-172 (10 
µM). ATP-induced CaCC current was increased by IL-13. (B) Short circuit 
current measured in HNE cells from DFNB4. ENaC and CFTR currents were 
not different between PBS and IL-13 treatment. But, ATP-induced CaCC 
current was increased by IL-13 treatment.
3. Anion exchanger expression and activity
In addition to SLC26A4, various anion exchangers, including AE2, AE3,
AE4, SLC26A3, SLC26A6, SLC26A7, SLC26A8, SLC26A9 and SLC26A11,
17
were found to be expressed in the HNE cells of the controls. When the cells 
were treated with IL-13, SLC26A3 was up-regulated (by 8.2 ± 5.4 fold 
compared to PBS treatment) along with SLC26A4. The other anion 
exchangers did not respond to IL-13 stimulation (Figure 5). We also 
examined anion channel activity by measuring the Cl-/HCO3- exchange ratio. 
The anion channel activity in epithelia from the patients harboring SLC26A4
mutations (DFNB4) (0.12 ± 0.07 ΔpH/min) was not different from that in the
controls (0.15 ± 0.06 ΔpH/min) under basal conditions. When the HNE cells
from the controls were treated with IL-13 for 7 days, the anion channel 
activity was significantly increased (0.23 ± 0.17 ΔpH/min, P<0.05), but not in 
the epithelia from patients with SLC26A4 mutations (0.18 ± 0.06 ΔpH/min) 
(Figure 6). The molecular and functional data indicate that pendrin is a major 
anion exchanger that responds to IL-13 and that the intracellular and ASL pH
may be regulated by various anion exchangers other than pendrin under basal 
conditions.
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Figure 5. Anion exchager expression in cultured human nasal epithelia 
from controls. Along with pendrin, various anion exchangers (AE2, AE3 and 
AE4) and SLC26A family transporters (SLC26A3, SLC26A6, SLC26A7, 
SLC26A8, SLC26A9 and SLC26A11) are expressed in nasal epithelia from 
controls (n=5). Only SLC26A3 is increased by IL-13 (10 ng/ml). * indicates 
p<0.05 compared with the PBS-treated cells.
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Figure 6. Anion exchange activity in human nasal epithelia cultured from 
patients with SLC26A4 mutations (DFNB4) and controls. (A) 
Representative tracings of anion channel activity. (B) Measurements of anion 
exchanger activity showing significantly increased activity following IL-13 
treatment (10 ng/ml) in the controls (n=4) but not in epithelia from patients 
harboring SLC26A4 mutations (DFNB4, n=5). * indicates p<0.05 compared 
with the PBS-treated cells.
4. MUC5AC expression and goblet cell differentiation
We also examined the role of pendrin in mucus secretion in the airway 
epithelia. Quantitative real-time PCR data showed that the expression of
MUC5AC, a goblet cell marker, was greatly increased by IL-13 treatment in 
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cultured cells from controls. In contrast, MUC5AC expression was 
comparatively low in cultured cells from DFNB4 patients, and it was not up-
regulated by IL-13 treatment (Figure 7A). PAS staining revealed goblet cell 
hyperplasia in the control HNE cells following IL-13 treatment, but this was 
not observed in the epithelia from DFNB4 subjects (Figure 7B). Histologic 
examination of the inferior turbinates also revealed that there was a much 
lower number of PAS-positive cells (3.7 ± 2.1/mm) in the nasal mucosa from 
DFNB4 patients compared with that from controls (10.3 ± 3.7/mm) (Figure
8).
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Figure 7. MUC5AC expression and goblet cell differentiation in cultured 
human nasal epithelial cells. (A) Real-time PCR analysis showing up-
regulation of MUC5AC by IL-13 (10 ng/ml) in controls (n=3). In contrast, 
MUC5AC is weakly expressed and does not respond to IL-13 in epithelia from 
patients carrying SLC26A4 mutations (DFNB4, n=3). * indicates p<0.05. (B) 
PAS staining showing goblet cell hyperplasia in nasal epithelial cells from 
controls following IL-13 treatment (10 ng/ml) for 7 days, but not in epithelia 
from DFNB4 patients. Scale bar represents 10 μm.
Figure 8. PAS staining of inferior turbinates. (A) Representative images 
shows a much lower amount of PAS staining in turbinate tissue from patients 
harboring SLC26A4 mutations (DFNB4) compared with the tissues from 
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controls (bars indicate 200 μm). (B) Quantitative analysis of the abundance of 
PAS-positive cells in 6 DFNB4 and 6 controls. * indicates p<0.05.
Figure 9. The hypothetical role of pendrin in the regulation of airway 
surface liquid (ASL). (A) Pendrin regulates ASL volume via Cl- and 
subsequent water absorption. The secreted HCO3- will evaporate, thus leading 
to net anion movement into the cell. Under inflammatory conditions, up-
regulated pendrin compensates for the over-secreted fluid caused by up-
regulated Cl- channels. (B) In pendrin-deficient airways, ASL thickness is 
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increased due to the lack of Cl- absorption by pendrin under basal conditions 
and cannot compensate for the over-accumulated fluid. 
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IV. DISCUSSION
A recent report13 indicates that pendrin is involved in the regulation of ASL 
thickness in mice. Although the ASL thickness did not differ in cultured 
tracheal epithelial cells between wild-type and pendrin-deficient mice under 
basal conditions, the ASL became much thicker in pendrin-deficient mice 
compared to the cells from wild-type mice after stimulation with an allergic 
cytokine.13 However, pendrin regulates the pH of the ASL but has little effect 
on fluid secretion in Calu-3 cells, which are human serous airway epithelial 
cells.24 Therefore, it was unclear whether pendrin regulates ASL volume in 
airway epithelia in humans. In our data, the expression pattern of ion 
transporters in airway epithelia was similar between the patients with 
SLC26A4 mutations and controls except for the weak expression of CFTR in 
patients with SLC26A4 mutations. However, the ASL layer was thicker in 
HNE cells from patients with SLC26A4 mutations compared to controls. 
These data indicate that pendrin is involved in ASL volume regulation even in 
basal conditions. This finding is not consistent with data from the mouse 
airway. This discrepancy may stem from species differences in the role of ion 
transporters in airway epithelia. For instance, the expression patterns of ion 
channels are quite different between mice and humans as CFTR expression is 
barely detectable in mouse airway epithelia. Another possible reason for the 
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conflicting results between reports may be attributable to a methodological 
problem. Nakagami et al.13 measured ASL thickness 3 min after PBS/dye 
loading, before ASL thickness had reached a steady state. 
The mechanism by which pendrin regulates ASL is puzzling because this 
electro-neutral transporter cannot generate an osmotic gradient. One possible 
mechanism underlying this phenomenon is the evaporation of secreted HCO3-, 
which results in net anion movement into the lumen and subsequent Na+
secretion, via ENaC, to generate osmotic pressure (Figure 9A). Interestingly, 
the difference of ASL height between normal and pendrin-deficient airway 
epithelia became much more prominent with IL-13 treatment. IL-13 induces 
airway fluid secretion and as a result, the ASL thickness is increased. In 
normal airway epithelial cells, the up-regulation of pendrin (~ 100 fold) 
following IL-13 treatment compensates for the thickened ASL via Cl-
absorption. However, presumably since this compensatory mechanism does 
not exist in the pendrin mutants, it results in an overaccumulation of ASL 
(Figure 9B).
Pendrin seems to be not only involved in ASL regulation, but also mucus 
secretion. Enforced expression of pendrin in NCI-H292 cells or mouse airway 
epithelia induces the up-regulation of MUC5AC.14 However, pendrin–
deficient mice exhibit impaired airway hyperresponsiveness and eosinophilic 
inflammation, but not mucus production. Our data showed that MUC5AC was 
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expressed at very low levels in the nasal epithelia from SLC26A4 mutants and 
was not up-regulated by IL-13 treatment, which contrasts with our findings in 
the cells of the controls. We also revealed that the goblet cell differentiation in 
basal condition and hyperplasia induced by IL-13 was minimal in the epithelia 
from patients with SLC26A4 mutations. Furthermore, we demonstrated that 
the proportion of goblet cells in the nasal mucosa from patients with 
SLC26A4 mutation is much lower compared to that in controls. These data all 
together indicate that pendrin is a major participant in mucous cell 
differentiation and hyperplasia induced by allergic cytokines in airway 
epithelia. Although the exact role of pendrin in mucus secretion in the airways 
is unclear, pendrin may be involved in the release of inflammatory cytokines 
or may activate transcription factors for the mucin gene, leading to mucus 
secretion, as suggested by Rose & Voynow.25
An interesting phenomenon is the linkage between the pathogenesis of 
asthma and pendrin. Pendrin knockout mice show less of an allergic response 
to OVA stimulation than their wild-type counterparts.13 Pendrin expression is 
up-regulated after IL-4 stimulation in cultured airway epithelia16 and disease 
tissues, such as those from asthma, COPD, and rhinitis patients.12,18,26
Moreover, patients with pendrin mutations had a tendency to be resistant to 
asthma.14 Based on our data, we postulate that the increase in ASL thickness 
observed in the airways of pendrin-deficient patients under basal conditions 
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may decrease the chance of allergens coming into contact with the airway 
epithelia, and therefore hinder the initiation of allergic sensitization. Moreover, 
the dramatic increase in ASL thickness induced by allergic cytokines could 
further protect the airway epithelia against exposure to allergens in pendrin-
deficient airways. Another possible mechanism explaining the lower 
incidence of asthma in patients harboring pendrin mutations is a defect in 
mucus secretion, although the exact molecular mechanism underlying this 
process is unclear. 
In summary, we showed that the ASL layer was thicker in human airway 
epithelial cells from patients with SLC26A4 mutation compared to controls, 
and this phenomenon was more prominent in allergic conditions. Pendrin 
seems to be essential in mucin expression and goblet cell development. These 
findings may explain the low incidence of allergic airway diseases in patients 
with SLC26A4 mutation. Specific blockers targeting pendrin in the airway 
epithelium may represent promising candidate drugs for the treatment of 
allergic airway diseases such as asthma and allergic rhinitis.
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V. CONCLUSION
In summary, we showed that the ASL layer was thicker in human airway 
epithelial cells from patients with SLC26A4 mutation compared to controls, 
and this phenomenon was more prominent in allergic conditions. Pendrin 
seems to be essential in mucin expression and goblet cell development. These 
findings may explain the low incidence of allergic airway diseases in patients 
with SLC26A4 mutation. Specific blockers targeting pendrin in the airway 
epithelium may represent promising candidate drugs for the treatment of 
allergic airway diseases such as asthma and allergic rhinitis.
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ABSTRACT (in Korean)
펜드린 결핍 인간 기도 상피세포에서
증가된 기도 표면 액체와 감소된 mucin 발현
<지도교수 최재영>
연세대학교 대학원 의과학과
이현재
펜드린은 음이온 교환 단백이며 이것의 돌연변이는 난청을
유발한다고 알려져 있다. 그러나 최근 기도 표면 액체의 양과
mucin 발현의 조절에 펜드린의 역할을 밝혀내기 위한 펜드린의
발현과 천식 같은 기도 질환의 관한 연구가 진행되었다. 
16 명의 펜드린 돌연변이를 가진 난청 환자와 17 명의 돌연변이를
가지고 있지 않은 환자로부터 얻은 인간 코 상피세포 배양하였다. 
세포에 Interleukin 13 을 처리하여 점액 과분비를 유도하였다. 
기도 표면 액체의 높이 측정과 실시간 중합효소 연쇄 반응을
이용하여 다양한 이온 운반체와 MUC5AC 를 발현량을 확인 하였다. 
pH 민감성 형광 프로브를 이용하여 음이온 교환 능력을 측정하였다. 
배양된 세포와 하위 갑개 조직에서 과아이오딘산 시프 염색을
시행하였다. 펜드린 돌연변이 세포의 기도 표면 액체는 실험군의
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기도 표면 액체보다 더 두꺼웠고, 이러한 차이는 Interleukin 13 을
처리하였을 때 현저하게 나타났다. 실험군에서 Interleukin 13 
처리 후 음이온 교환 능력이 증가한 반면 돌연변이 군에서는
차이를 보이지 않았다. 배상세포 변질형성은 실험군에서
나타났지만 돌연변이에서는 나타나지 않았다. 게다가  
과아이오딘산 시프 염색에 양성인 부분은 돌연변이 군에서 더 적게
나타났다. 
펜드린은 기도 표면 액체의 양과 mucin 발현 조절에 중요한 역할을
한다. 기도에 존재하는 펜드린을 표적으로 하는 특이 차단제는
알레르기성의 기도 질환 치료제로의 가능성을 가질 것이다. 
-------------------------------------------------------------------------------------------------------
핵심되는 말: SLC26A4, 천식, 음이온 통로
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